Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oncothyreon Inc (NASDAQ:ONTY)

1.02
Delayed Data
As of Feb 11
 0.00 / 0.00%
Today’s Change
1.00
Today|||52-Week Range
4.69
-54.05%
Year-to-Date
No recent news for Oncothyreon Inc.

Today’s Trading

Previous close1.02
Today’s open1.00
Day’s range1.00 - 1.07
Volume571,403
Average volume (3 months)1,141,159
Market cap$96.8M
Dividend yield--
Data as of 02/11/2016

Growth & Valuation

Earnings growth (last year)-3.23%
Earnings growth (this year)+50.00%
Earnings growth (next 5 years)+0.20%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.02

Competitors

 Today’s
change
Today’s
% change
NVIVInVivo Therapeutics ...+0.14+3.83%
RKDAArcadia Biosciences ...-0.08-3.33%
PRTOProteon Therapeutics...-0.05-0.68%
AVXLAnavex Life Sciences...+0.12+3.43%
Data as of 02/11/2016

Financials

Next reporting dateMarch 10, 2016
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$0.00
Annual profit (last year)-$50.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Christopher S. Henney
Chief Operating Officer
Gary W. Christianson
Corporate headquarters
Seattle, Washington

Forecasts

Partner Offers